Biogen, Inc. (BIIB)
189.06
+5.12
(+2.78%)
USD |
NASDAQ |
Mar 25, 16:00
189.00
-0.06
(-0.03%)
After-Hours: 20:00
Biogen Cash from Investing (Quarterly) : -1.232B for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -693.00M |
| Eli Lilly & Co. | -2.802B |
| Merck & Co., Inc. | -11.20B |
| AbbVie, Inc. | -1.463B |
| Pfizer Inc. | -6.146B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 511.90M |
| Cash from Financing (Quarterly) | -137.00M |
| Free Cash Flow | 1.969B |
| Free Cash Flow Per Share (Quarterly) | 2.738 |
| Free Cash Flow to Equity (Quarterly) | 334.20M |
| Free Cash Flow to Firm (Quarterly) | 460.64M |
| Free Cash Flow Yield | 7.10% |